Attovia Therapeutics, Inc.
ATTO
14 insider filings · Latest: Aug 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Aug 14 1:52 AM | Colin WalshDirector | Purchase | 500,000 | $17.00 | $8.5M | 3,020,632(I) | View → |
| Aug 5, 2026 | Aug 14 1:52 AM | Colin WalshDirector | Purchase | 85,000 | $21.00 | $1.8M | 85,000(I) | View → |
| Aug 5, 2026 | Aug 14 1:52 AM | Colin WalshDirector | Sale | 105,807 | $21.28 | $2.3M | 0(I) | View → |
| Aug 6, 2026 | Aug 14 1:51 AM | GOLDMAN SACHS GROUP INCOther | Purchase | 500,000 | $17.00 | $8.5M | 3,020,632(I) | View → |
| Aug 5, 2026 | Aug 14 1:51 AM | GOLDMAN SACHS GROUP INCOther | Purchase | 85,000 | $21.00 | $1.8M | 85,000(I) | View → |
| Aug 5, 2026 | Aug 14 1:51 AM | GOLDMAN SACHS GROUP INCOther | Sale | 105,807 | $21.28 | $2.3M | 0(I) | View → |
| Aug 6, 2026 | Aug 10 8:12 PM | venBio Global Strategic Fund IV, L.P.10% Owner | Purchase | 382,352 | $17.00 | $6.5M | 4,181,367(D) | View → |
| Aug 6, 2026 | Aug 8 1:47 AM | Redmile Group, LLC10% Owner | Purchase | 600,000 | $17.00 | $10.2M | 1,182,854(I) | View → |
| Aug 6, 2026 | Aug 7 7:45 PM | Sanofi10% Owner | Purchase | 300,000 | $17.00 | $5.1M | 1,082,855(I) | View → |
| Aug 6, 2026 | Aug 6 9:35 PM | Life Sciences Xi, L.P. Frazier10% Owner | Purchase | 588,235 | $17.00 | $10.0M | 6,154,213(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Aug 14 1:52 AM | Colin WalshDirector | Conversion | 22,627,105 | — | 0(I) | View → |
| Aug 6, 2026 | Aug 14 1:51 AM | GOLDMAN SACHS GROUP INCOther | Conversion | 22,627,105 | — | 0(I) | View → |
| Aug 6, 2026 | Aug 10 8:30 PM | Deep Track Biotechnology Master Fund, Ltd.10% Owner | Conversion | 18,181,818 | — | — | View → |
| Aug 6, 2026 | Aug 10 8:12 PM | venBio Global Strategic Fund IV, L.P.10% Owner | Conversion | 35,292,854 | — | 0(D) | View → |
| Aug 6, 2026 | Aug 8 1:47 AM | Redmile Group, LLC10% Owner | Conversion | 782,854 | — | 0(I) | View → |
| Aug 6, 2026 | Aug 7 7:45 PM | Sanofi10% Owner | Conversion | 782,855 | — | 0(I) | View → |
| Aug 6, 2026 | Aug 6 9:35 PM | Life Sciences Xi, L.P. Frazier10% Owner | Conversion | 51,007,956 | — | 0(D) | View → |
| Aug 4, 2026 | Aug 6 9:17 PM | Angie YouDirector | Grant/Award | 27,000 | $17.00 | 27,000(D) | View → |
| Aug 4, 2026 | Aug 6 9:17 PM | Mitchell GoldDirector | Grant/Award | 27,000 | $17.00 | 27,000(D) | View → |
| Aug 4, 2026 | Aug 6 9:16 PM | Zaneta OdrowazChief Business Officer | Grant/Award | 140,000 | $17.00 | 140,000(D) | View → |
| Aug 4, 2026 | Aug 6 9:15 PM | Petter VeibyChief Scientific Officer | Grant/Award | 140,000 | $17.00 | 140,000(D) | View → |
| Aug 4, 2026 | Aug 6 9:14 PM | Hubert ChenChief Medical Officer | Grant/Award | 140,000 | $17.00 | 140,000(D) | View → |
| Aug 4, 2026 | Aug 6 9:13 PM | Attovia Therapeutics, Inc.Chief Financial Officer | Grant/Award | 140,000 | $17.00 | 140,000(D) | View → |
| Aug 4, 2026 | Aug 6 9:11 PM | Attovia Therapeutics, Inc.Director, President and CEO | Grant/Award | 538,300 | $17.00 | 538,300(D) | View → |